As outlined previously in Section 2.5, AD is characterized by impaired insulin signaling, including reduced expression of insulin and IGF-1 receptors and altered phosphorylation of insulin receptor substrates (IRS) that shifts from tyrosine to serine residues [70,71,72]. The gene discussed is INS; the disease is Alzheimer disease.